J. McHutchison

发表

Clinical trial: the efficacy and safety of oral PF‐03491390, a pancaspase inhibitor – a randomized placebo‐controlled study in patients with chronic hepatitis C

E. Schiff, M. Shiffman, G. Burgess, 2010, Alimentary pharmacology & therapeutics.

Antiviral resistance and specifically targeted therapy for HCV (STAT‐C)

J. McHutchison, A. Thompson, J. McHutchison, 2009, Journal of viral hepatitis.

Review article: investigational agents for chronic hepatitis C

J. McHutchison, A. Thompson, J. G. McHutchison, 2009, Alimentary pharmacology & therapeutics.

Hepatitis C and G co‐infection: Response to interferon therapy and quantitative changes in serum HGV‐RNA

M. Alter, O. Nainan, J. Kolberg, 1997, Hepatology.

Insulin resistance and steatosis in hepatitis C virus infection

A. Zekry, A. Diehl, J. McHutchison, 2005, Gut.

Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection

N. Afdhal, J. McHutchison, N. Afdhal, 2007, Alimentary pharmacology & therapeutics.

Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase

J. Pawlotsky, K. Patel, S. Rigby, 2008, Journal of viral hepatitis.

Clinical trial: interferon alpha‐2b continuous long‐term therapy vs. repeated 24‐week cycles for re‐treating chronic hepatitis C

P. Marcellin, J. Albrecht, G. Davis, 2007, Alimentary pharmacology & therapeutics.

Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys

X. Lao, J. McCarthy, J. McHutchison, 2011, Journal of viral hepatitis.